503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.02%
Some net income increase while ZETA is negative at -177.36%. John Neff would see a short-term edge over the struggling competitor.
-24.51%
Negative yoy D&A while ZETA is 2.26%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
92.25%
Some yoy growth while ZETA is negative at -2600.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
7.93%
Less SBC growth vs. ZETA's 90669.23%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-47.87%
Both reduce yoy usage, with ZETA at -176.69%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
194.53%
AR growth well above ZETA's 339.83%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-221.91%
Both reduce yoy inventory, with ZETA at -306.92%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-89.59%
Both negative yoy AP, with ZETA at -305.45%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-172.94%
Both reduce yoy usage, with ZETA at -103.02%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-62.03%
Both negative yoy, with ZETA at -87.16%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
3.55%
Some CFO growth while ZETA is negative at -70.30%. John Neff would note a short-term liquidity lead over the competitor.
-3.44%
Negative yoy CapEx while ZETA is 19.90%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
70.85%
Acquisition growth of 70.85% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
22.77%
Purchases growth of 22.77% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-24.36%
We reduce yoy sales while ZETA is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-67.85%
We reduce yoy other investing while ZETA is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-20.37%
Both yoy lines negative, with ZETA at -17.33%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
60.29%
Issuance growth of 60.29% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-16.44%
We cut yoy buybacks while ZETA is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.